Almaden sets arbitration timeline versus Mexico

Executive Summary
- Almaden Minerals Ltd. announced the procedural calendar for its CPTPP arbitration claim against Mexico, with hearings set for December 14‑18 2026 in Washington, D.C.
- The claim seeks $1.06 billion in damages (subject to adjustment) for alleged expropriation and treaty breaches related to the Ixtaca precious metals project.
- Litigation is funded by up to US$9.5 million of non‑recourse financing secured in June 2024.
Key Details
- Arbitration Calendar:
- Mexico must file its counter‑memorial by Nov 24, 2025.
- Claimants’ reply due Apr 27, 2026; Mexico’s rejoinder due Aug 5, 2026.
-
Hearings scheduled Dec 14‑18, 2026 (reserve day Dec 19) in Washington, D.C.
-
Claim Background:
- Almaden owned 100% of the Ixtaca project; Almadex holds a 2.0% NSR royalty.
-
Alleged illegal actions by Mexico resulted in total loss of the investment and termination of mineral concessions.
-
Damages Sought:
-
Independent quantum expert valuation places aggregate damages at US$1.06 billion (subject to future updates for metal prices, FX, interest rates, etc.).
-
Financing:
-
The arbitration is financed by up to US$9.5 million in non‑recourse litigation funding from a leading legal‑finance counterparty (disclosed in the June 27 2024 press release).
-
Legal Basis:
- Claim filed under the Comprehensive and Progressive Agreement for Trans‑Pacific Partnership (CPTPP) with the United Mexican States.
-
Allegations include unlawful expropriation, denial of fair & equitable treatment, and discrimination against Almaden’s protected investments.
-
Historical Context Highlights:
- 2015 Ejido lawsuit over indigenous consultation; subsequent title reductions and appeals.
- 2022 Supreme Court (SCJN) ruling requiring proper indigenous consultation for mineral titles; later administrative actions led to suspension and eventual cancellation of titles.
- Company’s efforts to negotiate settlement remain ongoing despite continued prosecution of the claim.
Notable Quotes
No direct quotes were provided in the release.